US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

UBS analyst John Lovallo maintained a Buy rating on PulteGroup (PHM – Research Report) yesterday and set a price target of $151.00. The ...

UBS upgraded ResMed (RMD) to Buy from Neutral with a price target of $290, up from $255. The firm thinks consensus is too cautious in the ...

The threat of tariffs has loomed large over U.S. equities. Investors and strategists warn that high levies can reignite ...

Algert Global LLC acquired a new stake in shares of Microsoft Co. (NASDAQ:MSFT – Free Report) in the third quarter, according ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Blue Square Asset Management LLC lifted its position in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 2.5% in ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of ...

Q4 2024 Earnings Conference Call January 31, 2025 9:00 AM ETCompany ParticipantsSteve Keenan - Director of IRKen Lane ...

Detailed price information for JP Morgan Chase & Company (JPM-N) from The Globe and Mail including charting and trades.